PCI vs strategy for heart attack shock needing ECMO
Part of Heart & circulation clinical trials.
This study looks at the best way to reopen blocked heart arteries (using a stent procedure) in people who had a heart attack complicated by severe shock and need a life-support machine called VA-ECMO. It may help improve outcomes by testing which revascularization approach works best for multi-vessel blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old.
- You had a heart attack (STEMI or NSTEMI) and then developed severe shock requiring VA-ECMO.
- Your shock started within the last 24 hours.
- You have multiple blocked arteries that doctors think can be treated with planned primary PCI (stents).
- There is no known cause of shock other than the heart attack (such as infection/sepsis, blood loss, or a different obstruction).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial tests whether using a temporary heart pump plus close monitoring improves recovery in people with severe heart failure after a heart attack, compared to standard care.
This trial compares when to do a stent procedure (PCI) in people with NSTEMI who have disease in more than one coronary artery (non-IRA). It may help doctors choose the safest and most effective timing for treatment to improve outcomes.
This trial looks at a “precision” strategy for people in severe heart-related shock who are starting VA ECMO (a life-support machine). It will be done through a hospital registry system, which helps doctors learn which patients benefit most and why.
This trial studies whether an “early” or more “conservative” approach to improving blood flow to the leg can prevent limb damage during a type of heart-lung machine called peripheral VA-ECMO. It may help reduce the risk of poor leg blood flow (ischemia) in people with severe heart failure-related shock.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.